Full Programme for Breath Biopsy Conference 2020 Now Available
Published on: 9 Oct 2020, under Breath Biopsy
The Breath Biopsy Conference (#BBcon20) facilitates progress in the breath research field by bringing together researchers and research organizations who specialize in early diagnosis, precision medicine, metabolomics, analytical chemistry and beyond, to share the latest advances and to discuss common challenges in the breath research field. The two-day digital event took place on the 10th & 11th November 2020.
The programme provides everything you might want to know regarding the digital conference structure, talk titles and abstracts, and speakers’ information. The major focus this year will be on the latest advances on disease VOCs, breath biomarkers for liver disease, best practices for data analytics in breath research as well as a session reviewing some of the work and opportunities that have emerged throughout this year as a result of COVID-19.
Once again we will be welcoming three plenary speakers to the conference: Terence Risby from John Hopkins Bloomberg School of Public Health, who will be speaking on the first day, his talk title is ‘Lipid peroxidation, a measure of human homeostasis’; Renelle Myers from the BC Cancer Institute will present ‘Breath biomarkers for the early detection of lung cancer’ also on the first day; and Joachim Pleil from Gillings School of Global Public Health, who will be joining us on the second day to talk about ‘Exhaled breath aerosols: thoughts on sampling, analysis, and safety in the era of COVID-19’.
Alongside these exciting plenary sessions, we will begin the conference with an introductory session on the Applications of VOCs. Join this session to hear talks by Alan Griffiths from LECO, Stephen Fowler from University of Manchester, Agi Smoliska from Maastricht University, James Covington from University of Warwick and Anthony Hobson from the Functional Gut Clinic. The second session will be Breath Biomarkers for Liver Disease which will see Giuseppe Ferrandino from Owlstone Medical discuss recent published results from our work on using Breath Biopsy® to improve detection of liver disease biomarkers. He is joined by John Plevris of University of Edinburgh and Scott Friedman of Icahn School of Medicine at Mount Sinai who will both be presenting on non-alcoholic fatty liver disease (NAFLD) in their respective talks.
Following feedback from last year’s conference, the second day will feature a session for early career scientists to present their work. We are also bringing back the very popular panel discussion session, which this year will address ‘Why is it important for breath research to understand the biological origins of VOCs?’. We’re also including sessions on Study Design and Data Analytics and Breath Biopsy and COVID-19. Speakers on this day will include Julia Greenwood from Owlstone Medical, Roy Goodacre from the University of Liverpool, Pierre-Hugues Stefanuto from Liege University, Salman Siddiqui from the University of Leicester and Laura McGregor from Markes International. In the afternoon the focus will shift to COVID-19 research with James Logan from the London School of Hygiene and Tropical Medicine, the University of Loughborough’s Paul Thomas and Marc van der Schee from Owlstone Medical.
Alongside the main programme this year we are bringing you a conference app, allowing delegates to network with each other and giving you access to all of the information you might need throughout the conference together in one place. We’ll be sending an invitation to join the app to everyone who’s registered a few weeks before the conference starts.
We’re looking forward to welcoming you all to the conference to hear the talks, see the posters and participate in digital networking via the app. Take a look at the programme here.